CAS 69567-11-9

Piperidine,3,4,5-tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (2R,3R,4R,5S)-

Description:

Piperidine, 3,4,5-tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (2R,3R,4R,5S)- is a complex organic compound characterized by its piperidine ring structure, which is a six-membered saturated nitrogen-containing heterocycle. The compound features multiple phenylmethoxy groups, which contribute to its hydrophobic properties and potential for interactions with biological systems. The specific stereochemistry indicated by the (2R,3R,4R,5S) configuration suggests that the compound has defined spatial arrangements that can influence its reactivity and biological activity. This compound may exhibit properties typical of piperidine derivatives, such as potential use in medicinal chemistry, particularly in the development of pharmaceuticals. Its unique structure may allow for specific interactions with biological targets, making it of interest in drug design. Additionally, the presence of multiple aromatic groups can enhance its stability and solubility in organic solvents. Overall, this compound represents a significant example of how structural modifications can lead to diverse chemical properties and potential applications in various fields, including medicinal chemistry and materials science.

Formula: C₃₄H₃₇NO₄

Synonyms:

• Piperidine,3,4,5-tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, [2R-(2a,3b,4a,5b)]-
• Deoxynojirimycin tetrabenzylether

Deoxynojirimycin Tetrabenzyl Ether

CAS: 69567-11-9

Formula: C₃₄H₃₇NO₄

Purity: 95%

Molecular weight: 523.6619

Ref: IN-DA005KSB

Deoxynojirimycin Tetrabenzyl Ether

CAS: 69567-11-9

Deoxynojirimycin tetrabenzyl ether aids in making 1-dNM, a strong α-glucosidase I & II blocker.

Formula: C₃₄H₃₇NO₄

Color and Shape: Solid

Molecular weight: 523.673

Ref: TM-T37903

2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin

CAS: 69567-11-9

2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin is a synthetic atypical carbohydrate that has been shown to have anti-hyperglycemic and anti-hyperlipidemic effects. It is a benzylated derivative of the natural product 1-deoxynojirimycin. This compound has been shown to be effective in treating metabolic disorders such as polycystic ovary syndrome and hypercholesterolemia. 2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin may act by mimicking the actions of insulin and binding to insulin receptors on cells. This binding prevents the insulin receptor from being phosphorylated by an enzyme called protein kinase A (PKA), thereby inhibiting the action of PKA.

Formula: C₃₄H₃₇NO₄

Purity: Min. 95%

Molecular weight: 523.66 g/mol

Ref: 3D-MT146309